Localisation of insulin-like growth factor receptors in skin follicles of sheep (Ovis aries) and changes during an induced growth cycle.
Pelage growth cycles are regulated by circulating prolactin in many mammals, but the intercellular mediators of this signaling are unknown. Binding sites for insulin-like growth factors (IGFs) were examined in sheep skin to show changes in distribution and abundance of IGF receptors associated with a prolactin stimulus and the subsequent hair follicle growth cycle. Follicle cycles were induced in New Zealand Wiltshire ewes by a surge in plasma prolactin following a 4-month period of prolactin suppression with bromocriptine. Eight treated and three control sheep were slaughtered at intervals over 43 days during the follicle growth cycle. At 12-20 days after the elevation of prolactin, wool follicles passed through brief catagen and telogen phases, followed by a return to anagen. IGF binding sites were localized in skin sections by incubation with 125I-IGF-I or 125I-IGF-II. Displacement with competitive binding inhibitors (unlabeled IGF-I, IGF-II, des(1-3)IGF-I, des(1-6)IGF-II, or insulin) and affinity cross-linking showed that these binding sites were predominantly IGF type 1 and type 2 (mannose-6-phosphate) receptors. The radioligands bound especially to follicle germinal cells and prekeratinocytes. Increases in specific binding of both radioligands were observed after the rise in prolactin, but prior to anatomical changes in follicles associated with cessation of growth. For IGF-I, highest binding density was observed during catagen in the germinal matrix and dermal papilla cells. For IGF-II, peak density occurred during late anagen/early catagen in the germinal matrix and during telogen in the dermal papilla. These cycle associated changes in receptor availability suggest that IGF receptors are involved in control of the wool growth.
Nixon
A J
AJ
AgResearch, Ruakura Research Centre, Hamilton, New Zealand. nixona@agresearch.cri.nz
Ford
C A
CA
Oldham
J M
JM
Pearson
A J
AJ
D000818:Animals; D001345:Autoradiography; D001667:Binding, Competitive / Q000187:drug effects; D001971:Bromocriptine / Q000494:pharmacology; D003432:Cross-Linking Reagents; D018492:Dopamine Antagonists / Q000494:pharmacology; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D006128:Growth / Q000187:drug effects / Q000502:physiology*; D018859:Hair Follicle / Q000378:metabolism*; D008861:Microsomes / Q000378:metabolism; D011388:Prolactin / Q000097:blood; D017526:Receptor, IGF Type 1 / Q000378:metabolism*; D017527:Receptor, IGF Type 2 / Q000378:metabolism*; D012756:Sheep; D012867:Skin / Q000187:drug effects / Q000378:metabolism*
D003432:Cross-Linking Reagents; D018492:Dopamine Antagonists; D017527:Receptor, IGF Type 2; D001971:Bromocriptine; D011388:Prolactin; D017526:Receptor, IGF Type 1